New combo therapy aims to heal fragile skin
Disease control
Recruiting now
This study is testing if adding an IV immunoglobulin (IV IgG) treatment to an existing gene therapy (VYJUVEK) helps wounds heal better in people with Recessive Dystrophic Epidermolysis Bullosa (RDEB), a severe genetic skin condition. The main goal is to see if this combination re…
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC